Your browser doesn't support javascript.
loading
Using CRISPR/Cas to study gene function and model disease in vivo.
Tschaharganeh, Darjus F; Lowe, Scott W; Garippa, Ralph J; Livshits, Geulah.
Afiliación
  • Tschaharganeh DF; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lowe SW; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Garippa RJ; Howard Hughes Medical Institute, New York, NY, USA.
  • Livshits G; RNAi Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
FEBS J ; 283(17): 3194-203, 2016 09.
Article en En | MEDLINE | ID: mdl-27149548
ABSTRACT
The recent discovery of the CRISPR/Cas system and repurposing of this technology to edit a variety of different genomes have revolutionized an array of scientific fields, from genetics and translational research, to agriculture and bioproduction. In particular, the prospect of rapid and precise genome editing in laboratory animals by CRISPR/Cas has generated an immense interest in the scientific community. Here we review current in vivo applications of CRISPR/Cas and how this technology can improve our knowledge of gene function and our understanding of biological processes in animal models.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sistemas CRISPR-Cas Límite: Animals / Humans Idioma: En Revista: FEBS J Asunto de la revista: BIOQUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sistemas CRISPR-Cas Límite: Animals / Humans Idioma: En Revista: FEBS J Asunto de la revista: BIOQUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos